Skip to main content
Clinical Trials/NCT06582030
NCT06582030
Completed
Not Applicable

Stop Addiction Stigma Training Workshop With Case Vignettes to Decrease Stigmatizing Attitudes Toward People With Substance Abuse Disorders

Ohio State University Comprehensive Cancer Center1 site in 1 country93 target enrollmentStarted: October 17, 2023Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
93
Locations
1
Primary Endpoint
Stigmatizing attitudes

Overview

Brief Summary

This clinical trial evaluates the impact of a Stop Addiction Stigma (SAS) training workshop with a short description of the conditions related to addiction (vignettes) on stigmatizing attitudes toward individuals with substance abuse disorders. Reviews have shown that patients with substance abuse disorders have experienced negative attitudes from their health care providers. Negative attitudes may lead to less involvement from the provider and the patient and may lead to less effective care. Using case vignettes with a SAS workshop may be an effective method to help people learn about addiction, reduce the stigma toward addiction and improve the quality of health care.

Detailed Description

PRIMARY OBJECTIVE:

I. To describe the impact of SAS training on participants' responses to people with a substance impairment.

SECONDARY OBJECTIVES:

I. To evaluate the feasibility of stigma training workshops on stigmatizing attitudes health care personnel.

II. To explore the maintainability of responses over time. III. To explore relationships between language and stigmatizing attitudes.

OUTLINE: Participants are randomized to 1 of 6 group case vignettes.

GROUP A (CHRONICALLY RELAPSING BRAIN DISEASE): Participants view the chronically relapsing brain disease vignette and attend a SAS workshop on study.

GROUP B (BRAIN DISEASE): Participants view the brain disease vignette and attend a SAS workshop on study.

GROUP C (DISEASE): Participants view the disease vignette and attend a SAS workshop on study.

GROUP D (ILLNESS): Participants view the illness vignette and attend a SAS workshop on study.

GROUP E (DISORDER): Participants view the disorder vignette and attend a SAS workshop on study.

GROUP F (PROBLEM): Participants view the problem vignette and attend a SAS workshop on study.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Employee of Ohio State University Wexner Medical Center (OSUWMC)
  • Age ≥ 18 years
  • Participants must be able to read and comprehend survey items

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Stigmatizing attitudes

Time Frame: Before, immediately after and 8 weeks after the session

Stigmatizing attitudes will be measured with the Stigma and Attribution Assessment. The assessment score will be compared both between and within participants for each case vignette. Results will be reported with descriptive statistics, including means and standard deviations or medians and first-third quartiles for continuous variables, and frequencies and percentages for discrete variables.The linear mixed effect model will be used to study the repeated stigma and attribution measures over time (pre-workshop, immediately post-workshop, and 8 weeks post-workshop) within 6 vignettes as well as the effects between the vignettes, while controlling for the potential confounding factors (e.g., sex).

Secondary Outcomes

  • Attendance rate(At 90 minute session.)
  • Response to post-workshop evaluations(Before, immediately following and 8 weeks after the session.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Gretchen A McNally

Principal Investigator

Ohio State University Comprehensive Cancer Center

Study Sites (1)

Loading locations...

Similar Trials